Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"

Clinical trial NCT01030861 · COMPLETED

Trial details

NCT number: NCT01030861
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autoantibody Positive Non-diabetic Relatives at Risk for Type 1 Diabetes High Risk Impaired Glucose Tolerance

Start date: 2010-08-01
Primary completion: 2018-11-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.